Mithradote Bio Closes Oversubscribed $1 Million Seed Round for Development of the First Self-Administered Antidote Against Drink Spiking
October 02, 2024 08:57 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Mithradote Bio, a biotechnology company developing the first self-administered antidote against drink spiking, today announced the closure of an oversubscribed $1 million seed round. The…